A new study has demonstrated the potential impact of psilocybin-assisted therapy on people with depression, if approved by the FDA.

Individuals who consumed psilocybin in a therapeutic context reported modest, sustained improvements in sleep, with baseline sleep disturbances influencing the likelihood of achieving depression remission.

VR-based biofeedback effectively reduces depression and anxiety symptoms, matching conventional methods while enhancing user engagement through immersive environments, with potential for broader psychological and therapeutic benefits.

Start with leafy greens, fruit, tomatoes, and healthy fats.

A treatment for depression involving just two doses of psilocybin may have effects that last for years. A new follow-up study found that two-thirds of participants were still in remission five years after their therapy, pointing to its potential durability.

Physical feelings of anxiety tend to predict chronic stress markers better than depression symptoms, suggesting that past research linking depression to body strain may have picked up on hidden anxiety instead.